Completed
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
NCT02547818
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +12 more
- Locations
-
- Cognitive Clinical Trials Gilbert, Arizona, United States
- Xenoscience Phoenix, Arizona, United States
- Cognitive Clinical Trials Scottsdale, Arizona, United States
- Territory Neurology & Research Institute Tucson, Arizona, United States